SIOP PODC–adapted treatment guidelines for craniopharyngioma in low‐ and middle‐income settings

Pediatric craniopharyngioma is a rare tumor with excellent survival but significant long-term morbidities due to the loco-regional tumor growth or secondary to its treatment. Visual impairment, panhypopituitarism, hypothalamic damage, and behavioral changes are among the main challenges. This tumor should be managed under the care of a multidisciplinary team to determine the optimum treatment within the available resources. This is particularly important for low middle-income countries where resources are variable. This report provides risk-stratified management guidelines for children diagnosed with craniopharyngioma in a resource-limited setting.

[1]  S. Rivkees Thyroid Disorders in Children and Adolescents , 2021, Sperling Pediatric Endocrinology.

[2]  A Jackson,et al.  Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  H. Müller Childhood-onset craniopharyngioma: state of the art of care in 2018 , 2019 .

[4]  H. Müller,et al.  Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up , 2018, Expert review of neurotherapeutics.

[5]  C. Thiel,et al.  Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma , 2018, Journal of Neuro-Oncology.

[6]  C. Roth,et al.  Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection , 2018, The Journal of clinical endocrinology and metabolism.

[7]  R. Mekary,et al.  Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis. , 2018, World neurosurgery.

[8]  Grace Nelson,et al.  Delayed Puberty. , 2018, Pediatric annals.

[9]  G. Johannsson,et al.  The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up. , 2018, European journal of endocrinology.

[10]  I. Yilmaz,et al.  Comparison of visual acuity measurements via three different methods in preschool children: Lea symbols, crowded Lea symbols, Snellen E chart , 2018, International Ophthalmology.

[11]  M. Warmuth-Metz,et al.  Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007 , 2018, Endocrine.

[12]  D. Johnston,et al.  Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN , 2017, Neuro-oncology.

[13]  C. Catsman-Berrevoets,et al.  Very long-term sequelae of craniopharyngioma. , 2017, European journal of endocrinology.

[14]  P. Beck‐Peccoz,et al.  Central hypothyroidism — a neglected thyroid disorder , 2017, Nature Reviews Endocrinology.

[15]  Ari J. Wassner Pediatric Hypothyroidism: Diagnosis and Treatment , 2017, Pediatric Drugs.

[16]  T. Merchant,et al.  New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma , 2017, Nature Reviews Endocrinology.

[17]  J. Drake,et al.  Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experience , 2017, Child's Nervous System.

[18]  C. Thiel,et al.  First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma , 2017, Endocrine.

[19]  P. Murray,et al.  Diagnosis of growth hormone deficiency in the paediatric and transitional age. , 2016, Best practice & research. Clinical endocrinology & metabolism.

[20]  A. Olch,et al.  A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications. , 2016, Neurosurgical focus.

[21]  Patrick C Hanley,et al.  Thyroid Disorders in Children and Adolescents: A Review. , 2016, JAMA pediatrics.

[22]  C. Thiel,et al.  Oxytocin in survivors of childhood-onset craniopharyngioma , 2016, Endocrine.

[23]  Jennifer L Miller,et al.  Parent observed neuro-behavioral and pro-social improvements with oxytocin following surgical resection of craniopharyngioma , 2016, Journal of pediatric endocrinology & metabolism : JPEM.

[24]  Timothy R. Smith,et al.  Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study. , 2016, Journal of neurosurgery. Pediatrics.

[25]  M. Warmuth-Metz,et al.  Nuchal Skinfold Thickness: A Novel Parameter for Assessment of Body Composition in Childhood Craniopharyngioma , 2016, The Journal of clinical endocrinology and metabolism.

[26]  M. Didi,et al.  The diagnosis and treatment of adrenal insufficiency during childhood and adolescence , 2016, Archives of Disease in Childhood.

[27]  Elizabeth Dabrowski,et al.  Diabetes insipidus in infants and children. , 2016, Best practice & research. Clinical endocrinology & metabolism.

[28]  H. Müller Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity , 2015, Current opinion in endocrinology, diabetes, and obesity.

[29]  K. Makino,et al.  Quality of Life and Clinical Features of Long-Term Survivors Surgically Treated for Pediatric Craniopharyngioma. , 2016, World neurosurgery.

[30]  H. Müller Craniopharyngioma: long-term consequences of a chronic disease , 2015, Expert review of neurotherapeutics.

[31]  C. Thiel,et al.  A systematic review of cognitive performance in patients with childhood craniopharyngioma , 2015, Journal of Neuro-Oncology.

[32]  H. Müller,et al.  Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. , 2015, European journal of endocrinology.

[33]  H. Müller,et al.  Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma , 2015, Journal of pediatric endocrinology & metabolism : JPEM.

[34]  M. Dattani,et al.  Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence , 2015, Archives of Disease in Childhood.

[35]  M. Warmuth-Metz,et al.  Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. , 2015, Neuro-oncology.

[36]  M. Warmuth-Metz,et al.  Hydrocephalus and hypothalamic involvement in pediatric patients with craniopharyngioma or cysts of Rathke's pouch: impact on long-term prognosis. , 2015, European journal of endocrinology.

[37]  A. Albanese,et al.  Management of Electrolyte and Fluid Disorders after Brain Surgery for Pituitary/Suprasellar Tumours , 2015, Hormone Research in Paediatrics.

[38]  Cinzia Talamonti,et al.  Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  S. Bailey,et al.  Intracystic interferon therapy in childhood craniopharyngioma: who, when and how? , 2015, Clinical endocrinology.

[40]  R. Quinton,et al.  Transition in endocrinology: induction of puberty. , 2014, European journal of endocrinology.

[41]  G. Zada,et al.  Prevalence of Neurobehavioral, Social, and Emotional Dysfunction in Patients Treated for Childhood Craniopharyngioma: A Systematic Literature Review , 2013, PloS one.

[42]  L. Rylander,et al.  Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. , 2013, The Journal of clinical endocrinology and metabolism.

[43]  M. Mahmoud,et al.  Surprising outcome of ommaya reservoir in treating cystic craniopharyngioma: a retrospective study , 2013, British journal of neurosurgery.

[44]  M. Polak,et al.  Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. , 2013, The Journal of clinical endocrinology and metabolism.

[45]  T. Merchant,et al.  Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma. , 2013, International journal of radiation oncology, biology, physics.

[46]  H. Müller Childhood craniopharyngioma , 2020, Pituitary.

[47]  K. Auguste,et al.  A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma , 2013, Child's Nervous System.

[48]  S. Puget Treatment Strategies in Childhood Craniopharyngioma , 2012, Front. Endocrin..

[49]  J. Blair,et al.  Management of craniopharyngioma: the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system , 2012, Child's Nervous System.

[50]  K. Wang,et al.  Vasculopathy after intracystic bleomycin administration for a recurrent cystic craniopharyngioma: case report. , 2012, Journal of neurosurgery. Pediatrics.

[51]  J. Drake,et al.  Intracystic Therapies for Cystic Craniopharyngioma in Childhood , 2011, Front. Endocrin..

[52]  C. Roth,et al.  Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity , 2011, Front. Endocrin..

[53]  R. Kortmann Different Approaches in Radiation Therapy of Craniopharyngioma , 2011, Front. Endocrin..

[54]  T. Pietsch,et al.  Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. , 2011, European journal of endocrinology.

[55]  Jennifer L. Hammond,et al.  Functional analysis and treatment of aggressive behavior following resection of a craniopharyngioma , 2011, Developmental medicine and child neurology.

[56]  Christina Bougatsos,et al.  Screening for Visual Impairment in Children Ages 1–5 Years: Update for the USPSTF , 2011, Pediatrics.

[57]  S. Cavalheiro,et al.  Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. , 2010, Neurosurgical focus.

[58]  Charles Mayo,et al.  Radiation associated brainstem injury. , 2010, International journal of radiation oncology, biology, physics.

[59]  Adam P Dicker,et al.  Radiation dose-volume effects in the brain. , 2010, International journal of radiation oncology, biology, physics.

[60]  Joseph O Deasy,et al.  Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. , 2010, International journal of radiation oncology, biology, physics.

[61]  Charles Mayo,et al.  Radiation dose-volume effects of optic nerves and chiasm. , 2009, International journal of radiation oncology, biology, physics.

[62]  T. Pietsch,et al.  Analyses of Treatment Variables for Patients with Childhood Craniopharyngioma – Results of the Multicenter Prospective Trial KRANIOPHARYNGEOM 2000 after Three Years of Follow-Up , 2008, Hormone Research in Paediatrics.

[63]  S. Cavalheiro,et al.  Does the choice of surgical approach to insert an intratumoral catheter influence the results of intratumoral cystic treatment? , 2008, Surgical neurology.

[64]  C. Stratakis,et al.  Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics , 2008, Expert review of neurotherapeutics.

[65]  I. El Naqa,et al.  Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. , 2008, Journal of neurosurgery. Pediatrics.

[66]  S. Puget,et al.  Craniopharyngioma , 2007, Orphanet journal of rare diseases.

[67]  S. Puget,et al.  Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. , 2007, Journal of neurosurgery.

[68]  M. Flentje,et al.  Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma. , 2006, Klinische Padiatrie.

[69]  H. Müller,et al.  Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese patients with childhood craniopharyngioma , 2006 .

[70]  F. Saran,et al.  A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: a UK perspective. , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[71]  M. Hafez,et al.  Pediatric craniopharyngioma--rationale for multimodal management: the Egyptian experience. , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[72]  R. Mulhern,et al.  Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. , 2006, Journal of neurosurgery.

[73]  H. Müller,et al.  Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[74]  N. Boddaert,et al.  Craniopharyngioma: the pendulum of surgical management , 2005, Child's Nervous System.

[75]  S. Chokron,et al.  Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood , 2005, Child's Nervous System.

[76]  T. Yurtseven,et al.  Craniopharyngiomas in children: Turkey experience , 2005, Child's Nervous System.

[77]  K. Wang,et al.  Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas—a study in single institute , 2005, Child's Nervous System.

[78]  C. Sarkar,et al.  Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features , 2005, Child's Nervous System.

[79]  L. Solymosi,et al.  Differential diagnosis of suprasellar tumors in children. , 2004, Klinische Padiatrie.

[80]  A. Poretti,et al.  Outcome of craniopharyngioma in children: long-term complications and quality of life. , 2004, Developmental medicine and child neurology.

[81]  B. Larijani,et al.  Presentation and outcome of 93 cases of craniopharyngioma. , 2004, European journal of cancer care.

[82]  V. Nottidge,et al.  Craniopharyngioma in Nigerian children , 1988, Child's Nervous System.

[83]  Christoph Kniestedt,et al.  Visual acuity and its measurement. , 2003, Ophthalmology clinics of North America.

[84]  Matthew W. Wilson,et al.  Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001. , 2002, International journal of radiation oncology, biology, physics.

[85]  Zhen-yu Ma,et al.  Pediatric Craniopharyngiomas: Clinicomorphological Study of 189 Cases , 2002, Pediatric Neurosurgery.

[86]  Growth Hormone Research Society,,et al.  Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society , 2001 .

[87]  M. M. Ilondo,et al.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society , 2000 .

[88]  Y. Kanpolat,et al.  Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. , 2000, Neurosurgery.

[89]  J. Habrand,et al.  The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. , 1999, International journal of radiation oncology, biology, physics.

[90]  D. Riva,et al.  Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma , 1998, Child's Nervous System.

[91]  K. Watkins,et al.  Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? , 1996, Journal of neurosurgery.

[92]  S. Jani,et al.  A comparison of the roles of surgery and radiation therapy in the management of craniopharyngiomas. , 1987, International journal of radiation oncology, biology, physics.

[93]  L. Ghizzoni,et al.  Delayed puberty. , 2002, Best practice & research. Clinical endocrinology & metabolism.